Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age of Blood”

482 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 482 results

Not applicableStudy completedNCT03282942
What this trial is testing

Cardiovascular Effects of Aerobic and Strength Training in Hypertensive Middle-aged Individuals

Who this might be right for
Arterial Hypertension
Federal University of Rio Grande do Sul 60
Not applicableStudy completedNCT04577482
What this trial is testing

Study of Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12 Years or Older With Chronic Hepatitis C to Assess Sustained Virological Response

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 42
Not applicableStudy completedNCT04066283
What this trial is testing

Effects of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Women

Who this might be right for
TransgenderGender IdentityVascular Stiffness+5 more
University of Colorado, Denver 29
Not applicableStudy completedNCT00134602
What this trial is testing

Pediatric Impact: Promoting Adherence to Medications Among HIV-infected Children

Who this might be right for
HIV Infections
Centers for Disease Control and Prevention 180
Not applicableLooking for participantsNCT06455592
What this trial is testing

Effect of APA on Sleep Quality in Children With Cancer From 5 to 16 Years

Who this might be right for
Child, OnlyBlood CancerAdapted Physical Activity+1 more
University Hospital, Clermont-Ferrand 30
Early research (Phase 1)Study completedNCT00744692
What this trial is testing

Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant Disorders

Who this might be right for
Non Malignant DisordersImmunodeficienciesCongenital Marrow Failures+5 more
Duke University 22
Early research (Phase 1)Study completedNCT01973439
What this trial is testing

PENTA15: Pharmacokinetic Study of Once Versus Twice Daily Abacavir in HIV-1 Infected Children Aged 3 to <36 Months

Who this might be right for
HIV Infection
PENTA Foundation 23
Large-scale testing (Phase 3)Study completedNCT00404651
What this trial is testing

Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi Pasteur, a Sanofi Company 1,189
Not applicableStudy completedNCT02374619
What this trial is testing

Iron Supplementation and Eccentric Exercise

Who this might be right for
Muscle DamageOxidative Stress
University of Thessaly 28
Early research (Phase 1)UnknownNCT04566757
What this trial is testing

Safety and Efficacy of Human Umbilical Cord Blood Plasma Infusion for Age-Related Cognitive Decline

Who this might be right for
Age-related Cognitive Decline
American Academy of Regenerative Medicine 12
Large-scale testing (Phase 3)Study completedNCT01005407
What this trial is testing

Safety and Immunogenicity Study of the Hepatitis B Virus (HBV) Vaccine, HEPLISAV Compared to Engerix-B Vaccine

Who this might be right for
Healthy
Dynavax Technologies Corporation 2,452
Large-scale testing (Phase 3)Study completedNCT01203514
What this trial is testing

The Effects of Erythropoietin (EPO) on the Transfusion Requirements of Very Low Birth Weight Infants

Who this might be right for
Infant, NewbornInfant, Low Birth WeightInfant, Small for Gestational Age+2 more
NICHD Neonatal Research Network 318
Testing effectiveness (Phase 2)Study completedNCT00854087
What this trial is testing

Assess the Antifibrotic Activity of Fuzheng Huayu in Chronic Hepatitis C Patients With Hepatic Fibrosis

Who this might be right for
Chronic Hepatitis C Infection
Tarek Hassanein 118
Not applicableStudy completedNCT02119702
What this trial is testing

Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up)

Who this might be right for
HIV/AIDS
Harvard School of Public Health (HSPH) 818
Testing effectiveness (Phase 2)Study completedNCT00307567
What this trial is testing

Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488

Who this might be right for
Acellular PertussisTetanusHepatitis B+3 more
GlaxoSmithKline 689
Not applicableNot Yet RecruitingNCT07342023
What this trial is testing

Contribution of GFAP and UCH-L1 Assays in Whole Blood to Optimizing Personalized Care for "Repeated Fallers" Hospitalized in Geriatric Wards

Who this might be right for
Fallers Aged 60 Years and OlderBiomarkers / BloodIntracranial Bleeding
University Hospital, Clermont-Ferrand 770
Not applicableActive Not RecruitingNCT06446622
What this trial is testing

Brain Blood Flow Responses During Exercise: Younger Cohort

Who this might be right for
Cerebrovascular CirculationMagnetic Resonance Imaging
University of Wisconsin, Madison 45
Testing effectiveness (Phase 2)Looking for participantsNCT06679829
What this trial is testing

Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 215
Large-scale testing (Phase 3)UnknownNCT00435955
What this trial is testing

Comparison of High-Dose Chemotherapy + Rituximab and CHOP + Rituximab in High-Risk Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Azienda Ospedaliera San Giovanni Battista 240
Large-scale testing (Phase 3)Study completedNCT00352963
What this trial is testing

Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+2 more
GlaxoSmithKline 480
Load More Results